Nan Y - Search Results

1

Correction to: Consensus on the secondary prevention of primary liver cancer.

Nan Y, Xu X, Gao Y, Wang R, Li W, Yang M, Liu L, Duan Z, Jia J, Wei L, Zhuang H; Chinese Society of Hepatology, Chinese Medical Association. Nan Y, et al. Hepatol Int. 2022 Apr;16(2):484-485. doi: 10.1007/s12072-021-10288-2. Epub 2022 Jan 12. Hepatol Int. 2022. PMID: 35020155 Free PMC article. No abstract available.

2

Rosiglitazone prevents nutritional fibrosis and steatohepatitis in mice.

Nan YM, Fu N, Wu WJ, Liang BL, Wang RQ, Zhao SX, Zhao JM, Yu J. Nan YM, et al. Scand J Gastroenterol. 2009;44(3):358-65. doi: 10.1080/00365520802530861. Scand J Gastroenterol. 2009. PMID: 18991162

3

Antioxidants vitamin E and 1-aminobenzotriazole prevent experimental non-alcoholic steatohepatitis in mice.

Nan YM, Wu WJ, Fu N, Liang BL, Wang RQ, Li LX, Zhao SX, Zhao JM, Yu J. Nan YM, et al. Scand J Gastroenterol. 2009;44(9):1121-31. doi: 10.1080/00365520903114912. Scand J Gastroenterol. 2009. PMID: 19606393

4

[The role of heme oxygenase-1 in non-alcoholic steatohepatitis].

Wang RQ, Nan YM, Han F, Zhao SX, Fu N, Wu WJ. Wang RQ, et al. Zhonghua Gan Zang Bing Za Zhi. 2010 Sep;18(9):680-4. doi: 10.3760/cma.j.issn.1007-3418.2010.09.009. Zhonghua Gan Zang Bing Za Zhi. 2010. PMID: 20943080 Chinese.

5

Adenovirus-mediated peroxisome proliferator activated receptor gamma overexpression prevents nutritional fibrotic steatohepatitis in mice.

Nan YM, Han F, Kong LB, Zhao SX, Wang RQ, Wu WJ, Yu J. Nan YM, et al. Scand J Gastroenterol. 2011 Mar;46(3):358-69. doi: 10.3109/00365521.2010.525717. Epub 2010 Oct 24. Scand J Gastroenterol. 2011. PMID: 20969493

6

Heme oxygenase-1 prevents non-alcoholic steatohepatitis through suppressing hepatocyte apoptosis in mice.

Nan Y, Wang R, Zhao S, Han F, Wu WJ, Kong L, Fu N, Kong L, Yu J. Nan Y, et al. Lipids Health Dis. 2010 Oct 28;9:124. doi: 10.1186/1476-511X-9-124. Lipids Health Dis. 2010. PMID: 20979658 Free PMC article.

7

Peginterferon alpha-based therapy for chronic hepatitis B focusing on HBsAg clearance or seroconversion: a meta-analysis of controlled clinical trials.

Li WC, Wang MR, Kong LB, Ren WG, Zhang YG, Nan YM. Li WC, et al. BMC Infect Dis. 2011 Jun 9;11:165. doi: 10.1186/1471-2334-11-165. BMC Infect Dis. 2011. PMID: 21651820 Free PMC article.

8

[Peroxisome proliferator activated receptor gamma activation and overexpression prevent hepatocellular apoptosis of nutritional fibrotic steatohepatitis in mice].

Nan YM, Han F, Kong LB, Li Y, Wang RQ, Zhao SX. Nan YM, et al. Zhonghua Gan Zang Bing Za Zhi. 2011 Jul;19(7):521-6. doi: 10.3760/cma.j.issn.1007-3418.2011.07.013. Zhonghua Gan Zang Bing Za Zhi. 2011. PMID: 22152244 Chinese.

9

[Von Meyenburg syndrome: a case report].

Ren WG, Zhao SX, Nan YM. Ren WG, et al. Zhonghua Gan Zang Bing Za Zhi. 2011 Jul;19(7):560. doi: 10.3760/cma.j.issn.1007-3418.2011.07.023. Zhonghua Gan Zang Bing Za Zhi. 2011. PMID: 22152254 Chinese. No abstract available.

10

[The role of Fas mutation on non-alcoholic steatohepatitis in mice].

Su SS, Han F, Wang RQ, Ren WG, Wu WJ, Kong LB, Zhao SX, Nan YM. Su SS, et al. Zhonghua Gan Zang Bing Za Zhi. 2011 Sep;19(9):653-7. doi: 10.3760/cma.j.issn.1007-3418.2011.09.006. Zhonghua Gan Zang Bing Za Zhi. 2011. PMID: 22152378 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

905 results

Search Page